Author:
Xu Wen-Huan,Zhang Ting,Zhou Yunhai,Mao Yong
Funder
National Natural Science Foundation of China
Reference27 articles.
1. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment;Garrido-Castro;Cancer Discov.,2019
2. Effect of capecitabine maintenance therapy using lower dosage and higher frequency vs observation on disease-free survival among patients with early-stage triple-negative breast cancer who had received standard treatment;Wang;the SYSUCC-001 randomized clinical trial. JAMA,2021
3. Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer;Tutt;N. Engl. J. Med.,2021
4. Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis;Chen;Nat. Commun.,2022
5. RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype;Cai;Nat. Commun.,2019